Where CSF CXCL13 is reported
Also listed as: B-cell chemoattractant
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Lyme Disease | ↑ elevated | Non-neuroborreliosis controls | Neuroborreliosis — high specificity | Rupprecht et al. 2005 |
Frequently asked questions
In which conditions is CSF CXCL13 altered?
In the OSMF atlas CSF CXCL13 is reported in Lyme Disease. It is elevated in 1 across 1 entries.
Is there a standard clinical test for CSF CXCL13?
The atlas entries for CSF CXCL13 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal CSF CXCL13 result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.